Skip to content
OpenCapital
Get started

Pediatrix Medical Group MD Share Repurchase Authorization Limit

Share Repurchase Authorization Limit at other companies

ICU Medical logo
ICU MedicalICUI
$100M0.0%

Other financials

Income statement

See full
Revenue$476.2M+3.9%
Operating income$41.7M+29.8%
Net income$29.6M+42.6%
EPS (diluted)$0.36+50.0%

Balance sheet

See full
Cash & equivalents$205.8M+108%
Total debt$629.7M-3.9%
Total equity$878.6M+11.3%
Total assets$2.1B+3.9%

Cash flow

See full
Operating cash flow-$129.8M-10.5%
CapEx$6.2M+88.3%
Free cash flow-$136.1M-12.7%

Valuation

See full
Market cap$1.99B+42.9%
Enterprise value$2.41B+22.3%
P/E11.4×—
P/S1×+0.3×

Profitability

See full
Operating margin11.3%—
Net margin9%—
FCF margin12.3%+2.5pp

Returns & leverage

See full
Return on equity20.9%—
Debt / equity0.7×-0.1×
Current ratio1.3×-0.5×

Where this comes from

Reported directly by Pediatrix Medical Group in its filing.

Tagged under the XBRL concept us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1.

The official record: Pediatrix Medical Group’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pediatrix Medical Group's share repurchase authorization limit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pediatrix Medical Group's share repurchase authorization limit?
Pediatrix Medical Group (MD) reported share repurchase authorization limit of $146.3M in Q1 2026.
What is the long-term trend for Pediatrix Medical Group's share repurchase authorization limit?
Over 3 years (2020 to 2024), Pediatrix Medical Group's share repurchase authorization limit has grown at a -69.1% compound annual growth rate (CAGR), from $98.7M to $2.9M.
What does share repurchase authorization limit mean?
This represents the total dollar value or share count that the board of directors has authorized the company to spend on repurchasing its own common stock from the open market. It serves as a signal of management's confidence in the company's valuation and its commitment to returning capital to shareholders. This limit is an authorization, not an obligation to spend.